Compare
BioScience Health Innovations, Inc. vs Datacentrex, Inc. vs HeartCore Enterprises, Inc. vs Phunware, Inc.
| Latest fiscal year | BioScience Health Innovations, Inc. BHIC | Datacentrex, Inc. DTCX | HeartCore Enterprises, Inc. HTCR | Phunware, Inc. PHUN |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $5.69M | $6.96M | $8.97M | $2.55M |
| Revenue growth (YoY) | +208.3% | n/a | -60.5% | -19.9% |
| Gross margin | 57.0% | 48.9% | 35.1% | 50.6% |
| Operating margin | 12.6% | -113.7% | -34.8% | -803.7% |
| Net margin | 11.3% | -122.1% | 64.6% | -446.6% |
| Net income | $642.1K | -$8.50M | $5.79M | -$11.40M |
| EPS (Diluted) | $0.06 | -$0.46 | $0.22 | -$0.57 |
| Operating cash flow | $172.2K | -$6.45M | -$3.12M | -$12.47M |
| Free cash flow | n/a | -$32.39M | n/a | n/a |
| Cash & equivalents | $661.9K | $38.92M | $1.99M | $100.59M |
| Total assets | $1.71M | $66.84M | $13.06M | $120.87M |
| Total liabilities | $229.9K | n/a | $5.78M | $24.55M |
| Shareholders' equity | $1.48M | $66.25M | $8.78M | $96.32M |
| Return on year-end equity | 43.5% | -12.8% | 66.0% | -11.8% |
| Shares outstanding | 10.98M | 30.38M | 25.42M | 20.19M |
Revenue, most recent five fiscal years
| Fiscal year | BioScience Health Innovations, Inc. | Datacentrex, Inc. | HeartCore Enterprises, Inc. | Phunware, Inc. |
|---|---|---|---|---|
| Latest | $5.69M Ended 2025-12-31 | $6.96M Ended 2025-12-31 | $8.97M Ended 2025-12-31 | $2.55M Ended 2025-12-31 |
| 1 year earlier | $1.84M Ended 2024-12-31 | $741 Ended 2024-12-31 | $22.69M Ended 2024-12-31 | $3.19M Ended 2024-12-31 |
| 2 years earlier | $597.6K Ended 2023-12-31 | $2.0K Ended 2023-12-31 | $21.85M Ended 2023-12-31 | $4.83M Ended 2023-12-31 |
| 3 years earlier | $69.3K Ended 2022-12-31 | $2.4K Ended 2022-12-31 | $8.82M Ended 2022-12-31 | $6.52M Ended 2022-12-31 |
| 4 years earlier | n/a | $2.4K Ended 2021-12-31 | $10.82M Ended 2021-12-31 | $10.64M Ended 2021-12-31 |